CA2522632A1 - Molecules antagonistes du recepteur ccr5 - Google Patents

Molecules antagonistes du recepteur ccr5 Download PDF

Info

Publication number
CA2522632A1
CA2522632A1 CA002522632A CA2522632A CA2522632A1 CA 2522632 A1 CA2522632 A1 CA 2522632A1 CA 002522632 A CA002522632 A CA 002522632A CA 2522632 A CA2522632 A CA 2522632A CA 2522632 A1 CA2522632 A1 CA 2522632A1
Authority
CA
Canada
Prior art keywords
3alkyl
compound
carbon atoms
compounds
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002522632A
Other languages
English (en)
Inventor
Robert D. Williams
Ahmad Fawzi
El Hassane Lahlou
Original Assignee
AVANCE PHARMA INC.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AVANCE PHARMA INC. filed Critical AVANCE PHARMA INC.
Priority to CA002522632A priority Critical patent/CA2522632A1/fr
Priority to PCT/CA2006/001648 priority patent/WO2007038875A1/fr
Publication of CA2522632A1 publication Critical patent/CA2522632A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002522632A 2005-10-06 2005-10-06 Molecules antagonistes du recepteur ccr5 Abandoned CA2522632A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002522632A CA2522632A1 (fr) 2005-10-06 2005-10-06 Molecules antagonistes du recepteur ccr5
PCT/CA2006/001648 WO2007038875A1 (fr) 2005-10-06 2006-10-06 Molecules antagonistes du recepteur ccr5

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002522632A CA2522632A1 (fr) 2005-10-06 2005-10-06 Molecules antagonistes du recepteur ccr5

Publications (1)

Publication Number Publication Date
CA2522632A1 true CA2522632A1 (fr) 2007-04-06

Family

ID=37905946

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002522632A Abandoned CA2522632A1 (fr) 2005-10-06 2005-10-06 Molecules antagonistes du recepteur ccr5

Country Status (2)

Country Link
CA (1) CA2522632A1 (fr)
WO (1) WO2007038875A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2112145A1 (fr) * 2008-04-24 2009-10-28 AxoGlia Therapeutics S.A. Dérivés de chroménone utilisés pour le traitement des maladies neurodégénératives
CN116574035B (zh) * 2023-04-20 2024-03-08 扬州大学 一种含氨基甲酸酯的桃柁酚类衍生物、制备方法及应用

Also Published As

Publication number Publication date
WO2007038875A1 (fr) 2007-04-12

Similar Documents

Publication Publication Date Title
ES2240099T3 (es) Clorhidrato de un compuesto heterociclico fusionado.
CN111471021B (zh) 取代的二氨基甲酰胺和二氨基甲腈嘧啶，其组合物，和用其治疗的方法
CA2921314A1 (fr) Derives de nucleoside substitue comme inhibiteurs de prmt5
KR20070113252A (ko) 2,4-디아미노-피리도피리미딘 유도체 및 이의 ｍＴＯＲ억제제로서의 용도
US10858355B2 (en) Inhibitors of phosphatidylinositol 3-kinase gamma
JP5892620B2 (ja) ピラゾール誘導体
CA3087727A1 (fr) Derive de glucopyranosyle et utilisation associee
KR20030063414A (ko) 혈중 콜레스테롤 농도 저하제로서 유용한 당-치환된2-아제티딘온
US10676433B2 (en) Indole derivatives and their use in neurodegenerative diseases
US10464963B2 (en) Compounds from invasive Salvinias and methods of using the same
JP7129728B2 (ja) Ｆｇｆｒ４阻害剤として使用される縮環誘導体
CA2522632A1 (fr) Molecules antagonistes du recepteur ccr5
WO2000010560A1 (fr) Moyens de traitement ou de prevention contenant des composes de cyclopentenone comme principe actif
WO2020118178A1 (fr) Conjugués de monométhyl fumarate et d'un porteur et leurs méthodes d'utilisation
JP4233262B2 (ja) カルバ糖アミン誘導体及びそれを用いるグリコシダーゼ阻害剤
CN106608895A (zh) 一类具有糖环结构的bcl-2选择性抑制剂及其用途
JP4206271B2 (ja) カロポロシド誘導体、その製造方法およびその使用
Su et al. A Norsesterterpene Peroxide from a Marine Sponge Hippospongia sp
EP1848443A2 (fr) Composes utiles dans le traitement du vih
WO2018203564A1 (fr) Analogue de liphagal et inhibiteur de kinase multi-cible contenant du liphagal ou un analogue de celui-ci
JP2005511550A (ja) エトポシドおよび類似体の誘導体、ならびにそれを含有する医薬組成物
EP2539358A1 (fr) Analogues peptidiques
WO2023237730A1 (fr) Dérivés porteurs de triazolo et de spiro inhibant le vrs
Miranda et al. Bifunctional compound and its use in immunotherapy
CA2027023C (fr) Derives d'inosine/guanosine

Legal Events

Date Code Title Description
FZDE Dead